SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Managing Metabolic Syndrome Among Patients with Type 2 Diabetes Mellitus - A Narrative Review.
- DOI
- 10.2174/011871529x480529260812061106
- Published
- 2026 Sep 2
- Container
- Cardiovascular & hematological disorders drug targets
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2174/011871529x480529260812061106,
title = {SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Managing Metabolic Syndrome Among Patients with Type 2 Diabetes Mellitus - A Narrative Review.},
author = {Ahamed HZR and Al Rashid S and Balasubramanian R and Maideen NMP},
year = {2026},
journal = {Cardiovascular \& hematological disorders drug targets},
doi = {10.2174/011871529x480529260812061106},
url = {https://doi.org/10.2174/011871529x480529260812061106}
}RIS
TY - JOUR TI - SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Managing Metabolic Syndrome Among Patients with Type 2 Diabetes Mellitus - A Narrative Review. AU - Ahamed HZR AU - Al Rashid S AU - Balasubramanian R AU - Maideen NMP PY - 2026 JO - Cardiovascular & hematological disorders drug targets DO - 10.2174/011871529x480529260812061106 UR - https://doi.org/10.2174/011871529x480529260812061106 ER -
APA
HZR, A., S, A. R., R, B., & NMP, M. (2026). SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Managing Metabolic Syndrome Among Patients with Type 2 Diabetes Mellitus - A Narrative Review.. Cardiovascular & hematological disorders drug targets. https://doi.org/10.2174/011871529x480529260812061106
Source records
- pubmed · retrieved 2026-09-26T22:15:58.030Z